Agilon Health, Inc. (NYSE:AGL - Get Free Report) shares rose 4.9% during mid-day trading on Monday . The company traded as high as $1.38 and last traded at $1.40. Approximately 1,178,316 shares traded hands during trading, a decline of 84% from the average daily volume of 7,202,739 shares. The stock had previously closed at $1.33.
Wall Street Analyst Weigh In
AGL has been the subject of a number of research reports. Evercore ISI reduced their price objective on Agilon Health from $5.00 to $3.00 and set an "in-line" rating for the company in a research report on Wednesday, July 9th. Benchmark dropped their price objective on Agilon Health from $4.00 to $1.50 and set a "buy" rating on the stock in a research note on Wednesday, August 6th. The Goldman Sachs Group boosted their price target on Agilon Health from $2.50 to $5.00 and gave the company a "neutral" rating in a research note on Thursday, May 8th. Barclays lowered their price objective on Agilon Health from $3.00 to $1.50 and set an "underweight" rating on the stock in a research note on Wednesday, August 6th. Finally, Jefferies Financial Group lowered their price objective on Agilon Health from $2.40 to $1.10 and set a "hold" rating on the stock in a research note on Friday, August 15th. Four equities research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $3.07.
Read Our Latest Analysis on AGL
Agilon Health Stock Performance
The stock's 50-day moving average is $1.77 and its 200 day moving average is $2.91. The firm has a market cap of $528.39 million, a P/E ratio of -1.66 and a beta of 0.14.
Agilon Health (NYSE:AGL - Get Free Report) last released its earnings results on Monday, August 4th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.14). The firm had revenue of $1.39 billion for the quarter, compared to the consensus estimate of $1.47 billion. Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%.Agilon Health's revenue for the quarter was down 5.9% on a year-over-year basis. During the same quarter last year, the company posted ($0.07) EPS. On average, research analysts anticipate that Agilon Health, Inc. will post -0.59 EPS for the current year.
Hedge Funds Weigh In On Agilon Health
Large investors have recently modified their holdings of the business. Humankind Investments LLC acquired a new position in shares of Agilon Health during the 4th quarter worth about $30,000. Arrowpoint Investment Partners Singapore Pte. Ltd. acquired a new stake in Agilon Health in the 2nd quarter valued at about $31,000. Raymond James Financial Inc. acquired a new stake in Agilon Health during the fourth quarter worth approximately $33,000. 111 Capital bought a new stake in shares of Agilon Health during the second quarter worth approximately $36,000. Finally, Nisa Investment Advisors LLC increased its stake in shares of Agilon Health by 244.9% during the first quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company's stock worth $41,000 after purchasing an additional 6,783 shares during the period.
About Agilon Health
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Read More
Before you consider Agilon Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.
While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.